Sarepta Therapeutics Inc

Research Sarepta Therapeutics Inc (SRPT) on Bullrun: market cap USD 1.80B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSRPT
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.80B
• Financial periodFY2025
• RevenueUSD 1.86B
• Revenue growth4.3%
• Net income-USD 713.41M
• Free cash flow-USD 307.45M
• Gross margin98.6%

Valuation Snapshot

latest market cap is USD 1.80B.

About Sarepta Therapeutics Inc

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping;

Frequently asked questions

What is Sarepta Therapeutics Inc's market cap?

Sarepta Therapeutics Inc's market capitalization is USD 1.80B.

What does Sarepta Therapeutics Inc do?

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases.